Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2014
08/21/2014US20140235638 Anti-Infective Agents and Uses Thereof
08/21/2014US20140235634 Therapeutic compounds and uses thereof
08/21/2014US20140235629 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
08/21/2014US20140235628 Inhibitors of the Renal Outer Medullary Potassium Channel
08/21/2014US20140235622 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/21/2014US20140235620 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
08/21/2014US20140235608 Pyridinedione carboxamide inhibitors of endothelial lipase
08/21/2014US20140235588 Substituted 1h-pyrazol-1,2,4-oxadiazole derivatives as sphingosine receptor modulators
08/21/2014US20140235587 Substituted pyrazoles as sphingosine receptor modulators
08/21/2014US20140235586 Compounds for nonsense suppression, and methods for their use
08/21/2014US20140235584 Biaryl heterocycle substituted oxazolidinone antibacterial agents
08/21/2014US20140235583 Substituted pyrimidines
08/21/2014US20140234939 Benzamide Compounds and Related Methods of Use
08/20/2014EP2767536A1 Isoxazolo-pyridine derivatives
08/20/2014EP2766359A2 Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
08/20/2014EP2766358A1 Novel oxazine derivatives and their use in the treatment of disease
08/20/2014EP2766356A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof
08/20/2014EP2766354A1 Protein kinase inhibitors
08/20/2014EP2766353A1 2-oxo-piperidinyl derivatives
08/20/2014EP2766346A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/19/2014US8809549 Esters of bendamustine and related compounds, and medical use thereof
08/19/2014US8809548 Hepatitis C virus inhibitors
08/19/2014US8809539 Dicarboxylic acid derivatives as S1P1 receptor agonists
08/19/2014US8809530 Compositions of protein receptor tyrosine kinase inhibitors
08/19/2014US8809525 1,2,4-triazine-4-amine derivatives
08/19/2014US8809402 Oxazolone and pyrrolidinone-substituted biphenyls as P2X3 and P2X2/3 antagonists
08/19/2014US8809372 Pyridine derivatives
08/19/2014US8809369 Tetrahydroquinoline derivatives
08/19/2014US8809333 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
08/19/2014US8809326 Isoquinolinone Rho kinase inhibitors
08/19/2014US8809323 Therapeutic applications of pro-apoptotic benzodiazepines
08/19/2014CA2649924C Inhibitors of c-fms kinase
08/14/2014WO2014123882A1 2,6,7 substituted purines as hdm2 inhibitors
08/14/2014WO2014122674A1 Process for preparation of derivatives of tetrahydrophthalimide
08/14/2014WO2014122670A1 Carbodithioates with spermicidal activity and process for preparation thereof
08/14/2014WO2014122530A1 Novel functionalized 4-(phenoxymethyl(-1,3-dioxolane analogs exhibiting cytochrome p450 inhibition and their method of use
08/14/2014WO2014122474A1 Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
08/14/2014WO2014122067A1 New indanyloxydihydrobenzofuranylacetic acids
08/14/2014WO2014097151A3 Autotaxin inhibitors
08/14/2014US20140228582 Process for preparation of zolmitriptan
08/14/2014US20140228416 Substituted hydroxamic acids and uses thereof
08/14/2014US20140228377 Methylpiperidine derivative
08/14/2014US20140228376 Heterocyclic Compounds for the Treatment of CF
08/14/2014US20140228373 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
08/14/2014US20140228371 Quinoline and quinazoline amides as modulators of sodium channels
08/14/2014US20140228367 Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
08/14/2014US20140228363 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
08/14/2014US20140228362 Method of Treatment or Prophylaxis
08/14/2014US20140228360 Prmt5 inhibitors and uses thereof
08/14/2014US20140228359 Bis-indolic derivatives, their uses in particular as antibacterials
08/14/2014US20140228345 Substituted pyrazole azetidines as sphingosine receptor modulators
08/14/2014US20140228343 Prmt5 inhibitors and uses thereof
08/14/2014US20140228340 Benzonitrile derivatives as kinase inhibitors
08/14/2014US20140228321 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/13/2014EP2763982A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
08/13/2014EP2763979A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
08/13/2014EP2763977A1 Ethynyl derivatives as mglur5 allosteric modulators
08/13/2014EP2763971A1 Preparation of micafungin intermediates
08/13/2014EP2763970A1 Isoxazoline derivatives as insecticidal compounds
08/13/2014EP2763968A1 Herbicidal pyridazinone derivatives
08/13/2014CN103987710A 新的*嗪衍生物及它们在治疗疾病中的应用 * New piperazine derivatives and their use in the treatment of diseases
08/13/2014CN103987709A 用于制备可用作atr激酶抑制剂的化合物的方法 The method of preparing compounds useful as kinase inhibitors for use atr
08/13/2014CN103987701A N-(1,2,5-噁二唑-3-基)-、n-(1,3,4-噁二唑-2-基)-、n-(四唑-5-基)-和n-(三唑-5-基)-芳基甲酰胺及其作为除草剂的用途 N- (1,2,5- oxadiazol-3-yl) -, n- (1,3,4- oxadiazol-2-yl) -, n- (tetrazol-5-yl) - and n- (triazol-5-yl) - aryl carboxamide and their use as herbicides
08/13/2014CN103987699A 作为pi3k调节剂的喹唑啉衍生物 As quinazoline derivatives pi3k moderator
08/13/2014CN103987698A 作为激酶lrrk2调节剂用于治疗帕金森病的2-苯基氨基嘧啶衍生物 Amino-pyrimidine derivatives as kinase lrrk2 modifier used to treat Parkinson's disease 2-phenyl
08/13/2014CN103987694A 具有7-氨基-1,2,3,4-四氢喹啉结构的成色剂、包含它们的染色组合物、方法及用途 With a 7-amino-1,2,3,4-tetrahydroquinoline structure coupler, the dyeing compositions containing them, methods, and uses
08/13/2014CN103980267A 一类新型黄嘌呤氧化酶抑制剂的化合物及其药物组合物 A new class of compounds and drugs xanthine oxidase inhibitor compositions
08/13/2014CN103980266A 一种具有抗菌活性的化合物及其制备方法 A method for preparing a compound having antibacterial activity and
08/13/2014CN103980265A 3-苯基-5-(噻吩-2基)-1,2,4-噁二唑的合成工艺 Synthesis of 3-phenyl -5- (thiophen-2-yl) -1,2,4-oxadiazole
08/13/2014CN103980221A 4-（硝基苯基）-3-吗啉酮的制备方法及利用其制备利伐沙班的方法 4- (nitrophenyl) -3 morpholinone methods of preparation and use of its preparation method rivaroxaban
08/13/2014CN103980217A 一类蒎烷基异噁唑类化合物及其合成方法和应用 A class pinanyl isoxazole compounds and synthetic methods and applications
08/13/2014CN102850338B 一种含吡唑环的噁二唑类化合物及其制备与应用 Oxadiazole compounds containing the pyrazole ring and its preparation and application
08/13/2014CN102596939B 用于有机发光二极管发射层的化合物 The organic compound layer for the light emitting diode
08/12/2014US8802858 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
08/12/2014US8802855 Method for preparation of iloperidone and crystallization method thereof
08/12/2014US8802721 Thiophene compounds for inflammation and immune-related uses
08/12/2014US8802678 Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
08/12/2014US8802675 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/12/2014US8802674 Aminopyrimidine derivatives as LRRK2 modulators
08/12/2014US8802673 Heterocyclic amine derivatives
08/12/2014US8802670 Pharmaceutical compounds
08/12/2014US8802666 Inhibitors of cyclophilins and uses thereof
08/12/2014US8802665 Pyrrolidine derivatives
08/12/2014US8802657 Compounds useful as Raf kinase inhibitors
08/12/2014CA2707648C Isoxazolo-pyridine derivatives
08/12/2014CA2642376C Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
08/12/2014CA2621310C Sulfonamide derivative having pgd2 receptor antagonistic activity
08/07/2014WO2014121062A1 Selective hdac3 inhibitors
08/07/2014WO2014120815A1 Quinoline and quinazoline amides as modulators of sodium channels
08/07/2014WO2014120346A1 Factor ixa inhibitors
08/07/2014WO2014119947A1 Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as cetp inhibitors
08/07/2014US20140221663 Process for the preparation of benzohetero [1,3] - diazole compounds disubstituted with heteoaryl groups
08/07/2014US20140221659 Novel fxr (nr1h4) binding and activity modulating compounds
08/07/2014US20140221647 Phenoxazine derivatives and methods of use thereof
08/07/2014US20140221437 N-hetero-ring-substituted amide derivative
08/07/2014US20140221421 Therapeutic compounds
08/07/2014US20140221402 Quinazoline derivative and application thereof
08/07/2014US20140221396 Tubulin inhibitors
08/07/2014US20140221391 Cyclohexane derivative compound
08/07/2014US20140221383 Cetp inhibitors
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 647